Korean Skincare Brand JiYu Raises $6.5M to Expand U.S. Market, Tracking Toward $70M Revenue in 2026

Got story updates? Submit your updates here. ›

JiYu, a Korean skincare brand known for science-backed formulations developed and manufactured in South Korea, has raised $6.5 million in growth capital to expand across North America and accelerate clinical product development. The brand is tracking toward $70 million in annual revenue in 2026, representing triple-digit growth year over year.

Why it matters

JiYu's rapid growth has made it one of the most talked-about K-beauty brands in the United States, with a focus on bringing the full integrity of Korean skincare science directly to Western consumers. The brand's commitment to clinical evidence and ingredient transparency sets it apart in a crowded marketplace.

The details

JiYu maintains active operations in both Seoul, South Korea and the United States, embedding its product development team directly within Korea's world-leading beauty manufacturing ecosystem. All JiYu formulas are developed, tested, and produced in South Korea, giving the brand access to cutting-edge active compounds, proprietary delivery systems, and manufacturing standards that define the global benchmark in cosmetic innovation.

• JiYu is tracking toward $70 million in annual revenue in 2026.

What’s next

A significant portion of the newly secured capital will be directed toward initiating formal clinical studies to generate independent, peer-reviewed efficacy data on JiYu's core formulations.